Can people safely stop taking statins after turning 70? A new clinical trial has brought this question into focus, but its findings have also raised concerns about how the results should be interpreted.The discussion gained attention after cardiologist Dr Dmitry Yaranov, who shares medical insights on Instagram through the account @heart_transplant_doc, questioned the conclusion of a new study presented at the American Heart Association (AHA) 2026 meeting and published in the New England Journal of Medicine.In his Instagram post, Dr Yaranov pointed out that 12.7% of participants who stopped statins experienced a heart attack, ischaemic stroke or death, compared with 9.2% among those who continued taking the medication.He questioned whether describing discontinuation as non-inferior could make people believe that stopping statins was entirely risk-free. His concern is worth examining because statistical non-inferiority does not mean that both groups experienced identical outcomes.
What did the new STREAM trial actually find?
The STREAM trial included 1,880 adults aged 70 and above. Their average age was 77.5 years, and all had at least two chronic health conditions but no known cardiovascular disease.Participants were divided into two groups. One group stopped taking statins, while the other continued their medication. Researchers followed them for a median period of 103 weeks.
The results showed:
Stopped statins: 12.7% experienced a non-fatal heart attack, non-fatal ischaemic stroke or death.Continued statins: 9.2% experienced one of these outcomes.This represents a difference of 3.5 percentage points, or approximately 38% more events in relative terms in the group assigned to stop treatment.However, the researchers concluded that discontinuation was non-inferior to continuation for the primary outcome at two years.Non-inferiority does not mean both approaches produced identical results. It means the difference remained within a limit that researchers had decided in advance was statistically acceptable.
Why cardiologist Dr Dmitry Yaranov is questioning the findings
Dr Yaranov highlighted another important detail. Stopping statins did not produce meaningful improvements in muscle pain, quality of life, falls or sarcopenia in the trial.This challenges one common assumption that older adults will necessarily feel better or experience fewer physical problems after discontinuing cholesterol medication.He also drew attention to the independent data and safety monitoring board’s recommendation that participants assigned to stop statins discuss restarting treatment with their doctors.His broader argument was that discontinuation should depend on individual health circumstances, including frailty, life expectancy, adverse effects and cardiovascular risk, rather than age alone.
Did stopping statins improve muscle health or quality of life?
One common reason older adults consider stopping statins is the possibility of muscle-related side effects.Some people experience muscle pain, weakness or discomfort while taking these medicines. However, stopping treatment does not automatically mean these problems will disappear.The STREAM researchers specifically assessed muscle pain, quality of life, falls and sarcopenia, which refers to the gradual loss of muscle strength and muscle mass.they found no meaningful differences between the two groups in these areas. This means the study did not demonstrate a clear quality-of-life or muscle-health advantage from discontinuing statins.
Why stopping statins can be riskier for some older adults
Not everyone taking a statin has the same cardiovascular risk. This distinction is particularly important after 70.There are two different reasons doctors prescribe these medicines:Primary prevention: To reduce the chances of a first heart attack or stroke in someone who has not experienced one.Secondary prevention: To prevent another cardiovascular event in someone who has already experienced a heart attack, stroke or established cardiovascular disease.The STREAM trial examined primary prevention. Its findings should not be applied directly to people taking statins after a heart attack or stroke.For someone with established cardiovascular disease, stopping treatment without medical advice can remove an important part of their protection.Diabetes, high blood pressure, smoking, kidney disease, high LDL cholesterol and family history can also influence cardiovascular risk. Age alone cannot determine whether medication remains necessary.
